• Modern probiotic system Florica: the possibility of using in obstetrics and gynecology (Review article)

Modern probiotic system Florica: the possibility of using in obstetrics and gynecology (Review article)

HEALTH OF WOMAN. 2018.10(136):38–43; doi 10.15574/HW.2018.136.38

Kravchenko O. V.
HSSIU «Bukovinsky State Medical University», Chernivtsi

The article describes the characteristics of a normal vaginal microbiome, describes the structure and functions, shows the selective advantages of vaginal lactobacilli and their symbionts. It has been convincingly proven that vaginal microbiome is a dynamic system that is influenced by the physiological conditions of the body, exogenous factors, as well as the age of the woman. Pathogenetically substantiated changes in the vaginal microbiome in puberty, during pregnancy, in the postpartum period, in perimenopause, as well as in inflammatory and endocrine diseases of the female genitalia are also disclosed.

The necessity of using probiotics to correct and restore the normal vaginal biocenosis is substantiated. The requirements for probiotic therapy have been clarified. The advantages and disadvantages of their use are given. The probiotic system Florica is described in detail, its composition, the indicated advantages and the priority of this drug when used in obstetric-gynecological practice are considered.

Key words: Florica probiotic, vaginal microbial, use in obstetrics and gynecology.

REFERENCES

1. Ankirskaya AS. (2005). Bakterialnyiy vaginoz. Akusherstvo i ginekologiya 3:10–13.

2. Kira EF. (2008). Probiotiki v ginekologicheskoy praktike. Zhurnal ROAG 3:6–11.

3. Pyrohova VI, Feita YuR, Shurpiak SO. (2018). Klinichna efektyvnist korektsii stanu mikrobioty pikhvy u zhinok z porushenniamy reproduktyvnoho zdorovia i pisliapolohovymy uskladnenniamy v anamnezi. Zdorove zhenshchynу 5(131):36–39.

4. Plotko EE, Donnikov AE, Voroshilina ES, Hayutin LV, Tumbinskaya LV. (2011). Biotsenoz vlagalischa s tochki zreniya kolichestvennoy PTsR: chto est norma? Akusherstvo i ginekologiya 1:66–70.

5. Savitskaya KI, Vorobev AA, Molochkov VA, Zur NV. (2003). Normalnaya mikroflora genitalnogo trakta zdorovyih zhenschin reproduktivnogo vozrasta. Vestn. Ros. AMN 9:48–52.

6. Tutchenko LI, Ott VD, Marushko TL ta in. (2001). Osoblyvosti formuvannia systemy mikrobiotsenozu u novonarodzhenykh i nemovliat ta shliakhy yoho optymizatsii. Zhurn. praktychnoho likaria 5:24–30.

7. Shirobokov VP, Yankovskiy DS, Dyiment GS. (2010). Novyie strategii v oblasti sozdaniya i klinicheskogo ispolzovaniya probiotikov. Visnik farmakologіi ta farmatsіi 2:18–30.

8. Yankovskiy DS, Dyiment GS. (2008). Mikroflora i zdorove cheloveka. K, TOV «Chervona Ruta-Turs»:552.

9. Yankovskiy DS, Dyiment GS. (2007). Uluchshenie reproduktivnogo zdorovya zhenschiny putem optimizatsii mikroekologii pischevaritelnogo i urogenitalnogo trakta. Reprodukt. zdorove zhenschiny 3:148–154.

10. Yankovskiy DS, Dyiment GS. (2008). Ispolzovanie probiotikov s tselyu uluchsheniya reproduktivnogo zdorovya zhenschinyi. Zdorove zhenschiny 2(34):161–170.

11. Yankovskiy DS, Shirobokov VP, Dyiment GS. (2011). Integralnaya rol simbioticheskoy mikrofloryi v fiziologii cheloveka. K, TOV «Chervona Ruta-Turs»:169.

12. Yankovskiy DS, Shirobokov VP, Volosovets AP, Moiseenko RA, Dyiment GS. (2014). Mikrobiom cheloveka i sovremennyie metodyi ego ozdorovleniya. Zhurn. NAMNU 19;4:411-420.

13. Anderson BL, Cu-Uvin S, Raker CA et al. (2011). Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women. Acta Obstet Gynecol Scand. 5;90:510.

14. Anukam KC, Osazuwa EO, Ahonkhai I, Reid G. (2005). 16S rRNA gene sequence and phylogenetic tree of Lactobacillus species from the vagina of healthy Nigerian women. African Journal of Biotechnology. 4(11):1222–1227.

15. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW. (2006). Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microb Infect. 8:1450–1454. https://doi.org/10.1016/j.micinf.2006.01.003; PMid:16697231

16. Aroutcheva A, Gariti D, Simon M, Shott S, Farо, J, Simoes JA. (2001). Defense factors of vaginal lactobacilli. Am J Obstet Gynecol. 185:375–379.

17. Barrons R, Tassone D. (2008). Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther. 30(3):453-468. https://doi.org/10.1016/j.clinthera.2008.03.013; PMid:18405785

18. Bodean O, Munteanu O, Cirstoiu C et al. (2013). Probiotics a helpful additional therapy for bacterial vaginosis. J Med Life. 4; 6:434–436.

19. Bruce AW, Reid G. (1988). Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol. 34:339–343. https://doi.org/10.1139/m88-062; PMid:3138016

20. Burton JP, Cadieux PA, Reid G. (2003). Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol. 69:97–101. https://doi.org/10.1128/AEM.69.1.97-101.2003; PMid:12513982 PMCid:PMC152440

21. Cadieux P, Burton JC, Gardiner I. (2002). Lactobacillus strains and vaginal ecology. JAMA. 287:1940–2041. https://doi.org/10.1001/jama.287.15.1940; PMid:11960535

22. Colodner R, Edelstein H, Chazan B, Raz R. (2003). Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 5:767–769. PMid:14650098

23. Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. (2006). Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidophilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Minerva Ginecol. 58:227–231. PMid:16783294

24. Donders GG, Vereecken A, Bosmans E et al. (2002). Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 1;109:34–43. https://doi.org/10.1111/j.1471-0528.2002.00432.x

25. Dover SE, Aroutcheva AA, Faro S, Chikindas ML. (2008). Natural antimicrobials and their role in vaginal health: A short review. Int J Probiotics Prebiotics. 3:219–230. PMid:20657710 PMCid:PMC2908489

26. Ehrström S, Daroczy K, Rylander E, Samuelsson C et al. (2010). Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect. 12:691–699. https://doi.org/10.1016/j.micinf.2010.04.010; PMid:20472091

27. Eriksson KL, Carlsson B, Forsum U et al. (2005). A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal: clindamycin ovules. Acta Derm Venereol. 1;85:42–46. https://doi.org/10.1080/00015550410022249; PMid:15848990

28. Falagas ME, Betsi GI, Tokas T, Athanasiou S. (2006). Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs. 66(9):1253–1261. https://doi.org/10.2165/00003495-200666090-00007; PMid:16827601

29. Farage M, Maibach H. (2006). Lifetime changes in the vulva and vagina. Arch Gynecol Obstet. 273:195–202. https://doi.org/10.1007/s00404-005-0079-x; PMid:16208476

30. Farage M, Bramante M, Otaka Y, Sobel J. (2007). Do panty liners promote vulvovaginal candidiasis or urinary tract infections? A review of the scientific evidence. Eur J Obstet Gynecol Reproduct Biol. 132:8–19. https://doi.org/10.1016/j.ejogrb.2006.11.015; PMid:17204360

31. Fredricks DN, Fiedler TL, Marrazzo JM. (2005). Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 353:1899–1911. https://doi.org/10.1056/NEJMoa043802; PMid:16267321

32. Hillier S. (2005). The complexity of microbial diversity in bacterial vaginosis. N Eng J Med. 353:1886–1887. https://doi.org/10.1056/NEJMp058191; PMid:16267319

33. Homayouni A, Bastani P, Ziyadi S et al. (2014). Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit Tract Dis. 18(1):79–86. https://doi.org/10.1097/LGT.0b013e31829156ec; PMid:24299970

34. Klebanoff MA, Nansel TR, Brotman RM, Zhang J et al. (2010). Personal hygienic behaviors and bacterial vaginosis. Sex Transm Dis. 37:94–99. https://doi.org/10.1097/OLQ.0b013e3181bc063c; PMid:19823112 PMCid:PMC2811217

35. Krauss-Silva L, Moreira ME, Alves MB et al. (2010). Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol. Reproductive health. 7:14. https://doi.org/10.1186/1742-4755-7-14; PMid:20591191 PMCid:PMC2911410

36. Lamont RF, Sobel JD, Akins RA, Hassan SS et al. (2011). The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 118(5):533. https://doi.org/10.1111/j.1471-0528.2010.02840.x; PMid:21251190 PMCid:PMC3055920

37. Lepargneur JP, Rousseau V. (2002). Protective role of the Doderlein flora. J Gynecol Obstet Biol Reprod (Paris). 31:485–494.

38. Linhares IM, Giraldo PC, Baracat EC. (2010). New findings about vaginal bacterial flora. Revista da Associacao Medica Brasileira. 56;3:370–374. https://doi.org/10.1590/S0104-42302010000300026; PMid:20676549

39. Matu MN, Orinda GO, Njagi EN, Cohen CR, Bukusi EA. (2010). In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe. 16:210–215. https://doi.org/10.1016/j.anaerobe.2009.11.002; PMid:19925874

40. Miller L, Thomas K, Hughes JP. (2004). Randomised treatment trial of bacterial vaginosis to prevent post-abortion complication. BJOG. 11;9:982–988. https://doi.org/10.1111/j.1471-0528.2004.00230.x; PMid:15327614

41. Neeser JR, Granato D, Rouvet M, Servin A et al. (2000). Lactobacillus johnsonii La 1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology. 10:1193–1199. https://doi.org/10.1093/glycob/10.11.1193; PMid:11087711

42. Reid G, Bruce AW, Fraser N. (2001). Oral probiotics can resolve urogenital infection. FEMS Immunol Med Microbiol. 30:49–52. https://doi.org/10.1111/j.1574-695X.2001.tb01549.x; PMid:11172991

43. Ryckman KK, Simhan HN, Krohn MA, Williams SM. (2009). Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod. 15:131–137. https://doi.org/10.1093/molehr/gan081; PMid:19131402 PMCid:PMC2734163

44. Stoyancheva G, Danova S, Boudakov IY. (2006). Molecular identification of vaginal lactobacilli isolated from Bulgarian women. Antonie Van Leeuwenhoek. 90:201–210. https://doi.org/10.1007/s10482-006-9072-z; PMid:16871423

45. Wilks M, Wiggins R, Whiley A. (2004). Identification and H2O2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol. 42:13–17. https://doi.org/10.1128/JCM.42.2.713-717.2004; PMCid:PMC344438

46. Yamamoto T, Zhou X, Williams CJ, Hochwalt A, Forney LJ. (2009). Bacterial populations in the vaginas of healthy adolescent women. J Pediatr Adolesc Gynecol. 22:11–18. https://doi.org/10.1016/j.jpag.2008.01.073; PMid:19232297

47. Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. (2004). Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology. 150:2565–2573. https://doi.org/10.1099/mic.0.26905-0; PMid:15289553